drugset / Trial / NCT05736224
Assessing a Natural Product Plus Bioadhesive Nanoparticle (BNP) Sunscreen
Non-randomizedParallel-groupSingle-blindPrevention
Summary
The primary objective of this study is to evaluate the effects of a novel sunscreen formulation by assessing the extent of ultraviolet radiation (UVR)-induced direct and indirect cellular and DNA damage to human skin, in the presence vs absence of the sunscreen, in a population of healthy adults with fair skin (Fitzpatrick Scale type I, II or III).
Timeline
- Start
- 2023-05-15
- Primary completion
- 2023-09-01
- Completion
- 2023-09-01
Outcome
Met primary endpoint
registry analysis (superiority test); Sunscreen Formulation 1; p = 0.003; t-test, 2 sided; note: No sunscreen compared to test sunscreen NCT05736224 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Avobenzone | Small molecule | — | Topical |
| Subject | Cytisine | Small molecule | — | Topical |
| Subject | Diosmin | Small molecule | — | Topical |
| Subject | Ferulic Acid | Small molecule | — | Topical |
| Subject | Octocrylene | Small molecule | — | Topical |
| Subject | Resveratrol | Small molecule | — | Topical |